ARTICLE | Company News
BeiGene cancer news
August 24, 2015 7:00 AM UTC
BeiGene said it is establishing a biomanufacturing facility in BioBay, an innovation hub located in the Suzhou Industrial Park of Suzhou, China. It expects the cGMP facility to be completed by 2017. BeiGene said the new facility would manufacture compounds for clinical trials and support eventual commercial production. ...